EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8 + T cells

Jannis Wißfeld iD, Marvin Hering, Nora Ten Bosch, Guoliang Cui

European Journal of Immunology · 2024

DOI: 10.1002/eji.202350825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Jannis Wißfeld und 3 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Cyclosporine, Mechanistic Target of Rapamycin Complex 1, Immunosuppressive Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CRI Lloyd J. Old STAR Award, Institute of Health and Medicine, Hefei Comprehensive National Science Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclosporin A is a well‐established immunosuppressive drug used to treat or prevent graft‐versus‐host disease, the rejection of organ transplants, autoimmune disorders, and leukemia. It exerts its immunosuppressive effects by inhibiting calcineurin‐mediated dephosphorylation of the nuclear factor of activated T cells (NFAT), thus preventing its nuclear entry and suppressing T cell activation. Here we report an unexpected immunostimulatory effect of cyclosporin A in activating the mammalian target of rapamycin complex 1 (mTORC1), a crucial metabolic hub required for T cell activation. Through screening a panel of tool compounds known to regulate mTORC1 activation, we found that cyclosporin A activated mTORC1 in CD8 + T cells in a 3‐phosphoinositide‐dependent protein kinase 1 (PDK1) and protein kinase B (PKB/AKT)‐dependent manner. Mechanistically, cyclosporin A inhibited the calcineurin‐mediated AKT dephosphorylation, thereby stabilizing mTORC1 signaling. Cyclosporin A synergized with mTORC1 pathway inhibitors, leading to potent suppression of proliferation and cytokine production in CD8 + T cells and an increase in the killing of acute T cell leukemia cells. Consequently, relying solely on CsA is insufficient to achieve optimal therapeutic outcomes. It is necessary to simultaneously target both the calcineurin‐NFAT pathway and the mTORC1 pathway to maximize therapeutic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesCyclosporineMechanistic Target of Rapamycin Complex 1Immunosuppressive AgentsLymphocyte ActivationSignal TransductionAnimalsMiceProto-Oncogene Proteins c-aktNFATC Transcription FactorsHumansTOR Serine-Threonine KinasesCalcineurinMice, Inbred C57BLPhosphorylation3-Phosphoinositide-Dependent Protein KinasesCell ProliferationMultiprotein Complexes

Stichwörter der Autor:innen

AKTCD8+CsARibosomal protein S6T cellsmTOR

Substanzen

CyclosporineMechanistic Target of Rapamycin Complex 1Immunosuppressive AgentsProto-Oncogene Proteins c-aktNFATC Transcription FactorsTOR Serine-Threonine KinasesCalcineurin3-Phosphoinositide-Dependent Protein KinasesMultiprotein Complexes

Autor:innen und Institutionen

  • Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, Mainz, Germany.
  • T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
  • Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim (UMM), Mannheim, Germany.
  • Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science…

ORCID-Profile: Jannis Wißfeld

Förderung

  • CRI Lloyd J. Old STAR Award
  • Institute of Health and Medicine, Hefei Comprehensive National Science Center

Zitieren

APA

Wißfeld, J., Hering, M., Ten Bosch, N., & Cui, G. (2024). The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8 + T cells. European Journal of Immunology. https://doi.org/10.1002/eji.202350825

Vancouver

Wißfeld J, Hering M, Ten Bosch N, Cui G. The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8 + T cells. European Journal of Immunology. 2024. doi:10.1002/eji.202350825

BibTeX
@article{Wifeld2024,
  author = {Wißfeld, Jannis and Hering, Marvin and Ten Bosch, Nora and Cui, Guoliang},
  title = {The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8 + T cells},
  journal = {European Journal of Immunology},
  year = {2024},
  doi = {10.1002/eji.202350825}
}
Kostenlos starten →